PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied Materials
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied MaterialsView Video
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to mining
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to miningView Video

Latest Share Chat

AGM announces appointment of joint broker

23 Mar 2021 07:00

RNS Number : 1059T
Applied Graphene Materials PLC
23 March 2021
 

Applied Graphene Materials plc

 

("Applied Graphene Materials", "AGM", "the Group" or "the Company")

 

Appointment of joint broker

 

Applied Graphene Materials (LSE:AGM), the producer of speciality graphene nanoplatelet dispersions, announces the appointment of Allenby Capital Limited as the Company's joint broker with immediate effect.

 

N+1 Singer remains as the Company's nominated adviser and joint broker.

 

 

For further information, please contact:

 

 

Applied Graphene Materials plc

+44 (0) 1642 438 214

Adrian Potts, Chief Executive Officer

 

David Blain, Chief Financial Officer

 

 

 

N+1 Singer (Nominated Adviser and Joint Broker)

+44 (0) 207 496 3000

Peter Steel / Amanda Gray

 

 

 

Allenby Capital Limited (Joint Broker)

+44 (0) 203 328 5656

Nick Athanas / Liz Kirchner (Corporate Finance)

 

Matt Butlin / Kelly Gardiner (Sales and Corporate Broking)

 

 

Hudson Sandler

+44 (0) 207 796 4133

Charlie Jack / Emily Dillon

 

 

 

Notes to Editors

 

Applied Graphene Materials - For the last decade, AGM has been at the forefront of harnessing the possibilities of graphene. Founded originally by Professor Karl Coleman, the Group has grown from an academic idea from Durham University to a world leader in the development and application of graphene nanoplatelet dispersions for customers in the coatings, composites and functional materials sectors.

 

The Group utilises its proprietary bottom-up manufacturing process to produce high purity graphene nanoplatelets. Its expertise in dispersion chemistry enables AGM to create optimised, stable and easy to handle dispersions that customers use in real-world industrial products. AGM's unique approach enables industries to fully realise the potential of graphene in a simple, safe and easy to formulate way. 

 

AGM, based at the Wilton Centre on Teesside, was admitted to AIM in November 2013, raising £11 million. The Group successfully raised £8.5m in January 2016 and a further £9.8m in November 2017. Since August 2020, the Group's shares are also listed on OTCQB in the United States and, in January 2021, the Group successfully raised a further £6m gross. As a result of the funding support and their industry leading technology platform, AGM have been able to develop a significant sales distribution network covering Europe, North America and Asia. The Group continues to work closely with industrial partners, and have seen the successful launch of numerous commercial products enhanced by their Graphene Dispersions.

https://www.appliedgraphenematerials.com/

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
APPPPUPPWUPGPUP

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.